| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |